FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: B2B

  • Home
  •  | 
  • Tag Archives: "B2B"

FinCanna Advances Second Tranche of Capital to Refined Resin Technologies Inc.

FinCanna Advances Second Tranche of Capital to Refined Resin Technologies Inc.
This capital is the second in a series of tranches to be advanced as Refined Resin implements its three-phase development strategy to operationalize its legally zoned, large, state-of-the-art medical cannabis extraction laboratory. FinCanna with its recently completed financing of C$6.8 million is currently fully funded to make the additional payments as certain milestones are met.
Read more

Cannvas and CanvasRx Sign Letter of Intent

Cannvas and CanvasRx Sign Letter of Intent
With strong partnerships, a network of clinics, and access to, and information on hundreds of strains of medical cannabis from the top Licensed Producers in Canada, CanvasRx has developed a powerhouse of education and information for the cannabis industry. People use CanvasRx to learn about medical cannabis, find knowledgeable doctors, select strains and track their outcomes with Patient Reporting tools developed by physicians.
Read more

PUF VENTURES PROVIDES UPDATE REGARDING THE BUSINESS OF NATURES HEMP CORP.

PUF VENTURES PROVIDES UPDATE REGARDING THE BUSINESS OF NATURES HEMP CORP.
Natures Hemp, a biotechnology and consumer products company focused on unlocking the true value of the hemp for both B2B and B2C markets, and Cannvas MedTech Inc., a leading business technology company within the cannabis space, are pleased to announce the signing of a letter of intent to negotiate in good faith a data analytics agreement, for which Cannvas will provide industry insight and analytical modelling capabilities to Natures Hemp business models and Key Performance Indicators (KPIs).
Read more